Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
Share · CNE000001808 (XSHG)
Overview
No Price
Closing Price XSHG 31.10.2025: 45,13 CNY
31.10.2025 07:00
Current Prices from Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
ExchangeTickerCurrencyLast TradePriceDaily Change
XSHG: SSE
SSE
600329.SS
CNY
31.10.2025 07:00
45,13 CNY
2,96 CNY
+7,02 %
Share Float & Liquidity
Free Float 35,47 %
Shares Float 232,27 M
Shares Outstanding 654,8 M
Company Profile for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Share
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and healthcare products primarily in the People's Republic of China. It operates in Chinese Medicine and Western Medicine segments. The company is also involved in the manufacture and sale of Chinese and western pharmaceutical and biological products; wholesale and retail sale of medicines, biochemical pharmaceutical products, and daily use products; and operation of hospitals. In addition, it provides logistics, stocks, equipment installation, and medicine processing services; medicine inspection and testing services; and pharmaceutical consultancy services. The company sells its medicinal products under its own brand to the wholesalers; and purchases medicinal products under other brands from distributors and sells these to other wholesalers. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited was incorporated in 1992 and is based in Tianjin, the People's Republic of China.
Get up to date insights from finAgent about Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Company Data

Name Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
Company Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
Website https://www.zhongxinp.com
Primary Exchange XSHG SSE
ISIN CNE000001808
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Lei Wang
Market Capitalization 27 Mrd.
Country China
Currency CNY
Employees 4,6 T
Address Zhong Xin Mansion, 300193 Tianjin
IPO Date 2001-06-06

Ticker Symbols

Name Symbol
SSE 600329.SS
More Shares
Investors who hold Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited also have the following shares in their portfolio:
BANK OF AMERICA CORPORATION 8.50% BR NTS 31/08/27
BANK OF AMERICA CORPORATION 8.50% BR NTS 31/08/27 Bond
INVESTEC BANK PLC IMP TRPL IDX 6YR CONV NTS 26/07/22
INVESTEC BANK PLC IMP TRPL IDX 6YR CONV NTS 26/07/22 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025